BY TIMOTHY W. MARTIN, MARK MAREMONT AND JONATHAN D. ROCKOFF
The Massachusetts specialty pharmacy linked to a deadly meningitis outbreak had its products tested at an independent lab, which in May stated that samples from a batch of steroids—later implicated in the meningitis—were "sterile," according to documents reviewed by The Wall Street Journal.
But experts said the sample size that apparently was tested was too small to be meaningful and didn't comply with industry guidelines.
The lab's report was provided by the pharmacy, New England Compounding Center, to at least one customer, a clinic that had started purchasing injections from the company. The customer, which didn't buy steroids linked to ...To continue reading Wall Street Journal a subscription is required, click here
No comments:
Post a Comment